University of Texas/Texas AM Investment Management Co (UTIMCO) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$9.33M |
| 2 |
CMA
Comerica
CMA
|
+$323K |
| 3 |
Invesco
IVZ
|
+$202K |
| 4 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$160K |
| 5 |
Vanguard Energy ETF
VDE
|
+$135K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.13M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$487K |
| 3 |
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
|
+$428K |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$304K |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$283K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.22% |
| 2 | Energy | 16.24% |
| 3 | Healthcare | 16.1% |
| 4 | Materials | 2.63% |
| 5 | Financials | 1.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Johnson & Johnson
JNJ
$629B
| – | – |
-47
| Closed | -$6K |
|
27
Park Hotels & Resorts
PK
$2.99B
| – | – |
-9,587
| Closed | -$258K |
|
28
Warner Bros
WBD
$69.3B
| – | – |
-115
| Closed | -$3K |
|
|
29
ExxonMobil
XOM
$657B
| – | – |
-14,000
| Closed | -$1.13M |
|
|
JNCE
30
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| – | – |
-30,488
| Closed | -$428K |
|
|
GBT
31
DELISTED
Global Blood Therapeutics, Inc.
GBT
| – | – |
-17,800
| Closed | -$487K |
|
|
DISCK
32
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| – | – |
-290
| Closed | -$7K |
|
|
MON
33
DELISTED
Monsanto Co
MON
| – | – |
-515
| Closed | -$61K |
|
Similar funds
University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q3 2017 Portfolio in Review
As of Q3 2017, University of Texas/Texas AM Investment Management Co (UTIMCO) held 33 positions worth $41.7M, up 24% from $33.6M the previous quarter. Its ten largest holdings account for 90% of the portfolio.
University of Texas/Texas AM Investment Management Co (UTIMCO) deployed $6.96M of net new capital in Q3 2017, opening 9 new positions and adding to 3 existing holdings. Its largest new stake was Comerica: 4,510 shares worth $343K.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 7.3% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $304K trimmed.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s largest Q3 2017 buy was Comerica: 4,510 shares worth $343K.
- University of Texas/Texas AM Investment Management Co (UTIMCO) added most to Texas Instruments in Q3 2017, an estimated $9.33M increase.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s biggest Q3 2017 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $304K.
- University of Texas/Texas AM Investment Management Co (UTIMCO) fully exited ExxonMobil in Q3 2017, selling an estimated $1.13M.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s ten largest holdings make up 90% of its $41.7M portfolio in Q3 2017.
- University of Texas/Texas AM Investment Management Co (UTIMCO) opened 9 new positions and closed 8 in Q3 2017.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio value rose 24% quarter-over-quarter to $41.7M.
Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q3 2017, filed 13 Nov 2017.